Table 4.
Time | Assessment tool 1 | Assessment tool 2 | N | Kendall’s tau-b |
---|---|---|---|---|
Baseline | PHQ-9 | BDI-II | 14081 | 0.6294 |
3 months | R-SMS-DS | PHQ-9 Total | 2202 | 0.5704 |
R-SMS-DS | PHQ-9 item 1 | 2192 | 0.5279 | |
R-SMS-DS | PHQ-9 item 2 | 2202 | 0.5316 | |
R-SMS-DS | PHQ-9 item 3 | 2192 | 0.3967 | |
R-SMS-DS | PHQ-9 item 4 | 2192 | 0.4206 | |
R-SMS-DS | PHQ-9 item 5 | 2182 | 0.4319 | |
R-SMS-DS | PHQ-9 item 6 | 2192 | 0.5673 | |
R-SMS-DS | PHQ-9 item 7 | 2202 | 0.4213 | |
R-SMS-DS | PHQ-9 item 8 | 2192 | 0.3786 | |
R-SMS-DS | PHQ-9 item 9 | 2202 | 0.4166 | |
12 months | PHQ-9 | BDI-II | 5483 | 0.6632 |
1All patients screened at baseline.
2Patients in the SMS sub-study with text replies received within +/− 6 days of date of PHQ-9 completion.
3All patients in the ACUDep trial with response data.